Uncovering Critical Biomarkers, Immune Signatures, and Drug Candidates in Thyroid Cancer: A Systems Biology Approach

Thyroid cancer (THCA) is the most common endocrine malignancy associated with clinical challenges like recurrence, aggressive variants, and therapy resistance. This study employed an integrative systems-biology approach to interrogate The Cancer Genome Atlas (TCGA)-THCA transcriptomic data to identify candidate genes and drug–target relationships for THCA. Differentially expressed genes (DEGs) were identified and used to construct protein–protein interaction and gene regulatory network (GRN) as well as generate topological, clustering, and enrichment analyses. Candidate genes were interrogated using survival analysis, genetic alteration, correlation, immune infiltration, drug–gene interaction, and molecular docking. Findings were independently validated in two Gene Expression Omnibus (GEO) cohorts. A total of 424 DEGs (191 up-regulated, 233 down-regulated) were identified. Seven candidate genes, DPP4, GABRB2, HMGA2, SERPINA1, ADH1B, KLHDC8A , and DLG2 , were prioritized, and enrichment analyses revealed functional associations with extracellular matrix remodeling, MAPK signaling, cell-junction regulation, and synaptic signaling. These candidate genes displayed immune infiltration disparities and differential expression in independent GEO datasets. Docking simulations predicted favorable binding geometries for Sitagliptin- DPP4 and Flumazenil- GABRB2 , while 100-ns molecular dynamics simulations further authenticated the binding affinities of these two complexes. In conclusion, we identified independent candidate genes and in-silico prioritized drug–target interactions for further preclinical investigations of THCA.

Authors

Institutions

Publication Details

Journal
OMICS A Journal of Integrative Biology
Published
2026-11-18
DOI
https://doi.org/10.1177/15578100261503123
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Uncovering Critical Biomarkers, Immune Signatures, and Drug Candidates in Thyroid Cancer: A Systems Biology Approach

Amir Savardashtaki, Zeinab Dehghan, Asma Vafadar, Abbas Alibakhshi et al.
OMICS A Journal of Integrative Biology
Thyroid Cancer Diagnosis and Treatment
article

Uncovering Critical Biomarkers, Immune Signatures, and Drug Candidates in Thyroid Cancer: A Systems Biology Approach

Amir Savardashtaki, Zeinab Dehghan, Asma Vafadar, Abbas Alibakhshi, Maryam Zohrabzadeh
article en

Abstract

Thyroid cancer (THCA) is the most common endocrine malignancy associated with clinical challenges like recurrence, aggressive variants, and therapy resistance. This study employed an integrative systems-biology approach to interrogate The Cancer Genome Atlas (TCGA)-THCA transcriptomic data to identify candidate genes and drug–target relationships for THCA. Differentially expressed genes (DEGs) were identified and used to construct protein–protein interaction and gene regulatory network (GRN) as well as generate topological, clustering, and enrichment analyses. Candidate genes were interrogated using survival analysis, genetic alteration, correlation, immune infiltration, drug–gene interaction, and molecular docking. Findings were independently validated in two Gene Expression Omnibus (GEO) cohorts. A total of 424 DEGs (191 up-regulated, 233 down-regulated) were identified. Seven candidate genes, DPP4, GABRB2, HMGA2, SERPINA1, ADH1B, KLHDC8A , and DLG2 , were prioritized, and enrichment analyses revealed functional associations with extracellular matrix remodeling, MAPK signaling, cell-junction regulation, and synaptic signaling. These candidate genes displayed immune infiltration disparities and differential expression in independent GEO datasets. Docking simulations predicted favorable binding geometries for Sitagliptin- DPP4 and Flumazenil- GABRB2 , while 100-ns molecular dynamics simulations further authenticated the binding affinities of these two complexes. In conclusion, we identified independent candidate genes and in-silico prioritized drug–target interactions for further preclinical investigations of THCA.

OMICS A Journal of Integrative Biology
Hamedan University of Medical Sciences (IR), Shiraz University (IR), Shiraz University of Medical Sciences (IR)
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon